We are live on ! Find out more
IC

Inverness Counsel Portfolio holdings

AUM $1.8B
1-Year Est. Return 9.9%
This Fund
S&P 500
This Quarter Est. Return
+0.36%
1 Year Est. Return
-9.9%
3 Year Est. Return
+53.95%
5 Year Est. Return
+113.88%
10 Year Est. Return
AUM
$1.29B
AUM Growth
-$2.2M
Cap. Flow
+$4.85M
Cap. Flow %
0.38%
Top 10 Hldgs %
42.86%
Holding
102
New
5
Increased
23
Reduced
41
Closed
6

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$16M
2
MCO icon
Moody's
MCO
+$13.5M
3
DIS icon
Walt Disney
DIS
+$10.7M
4
TJX icon
TJX Companies
TJX
+$9.63M
5
ABBV icon
AbbVie
ABBV
+$8.87M

Sector Composition

Rank Sector Weight
1 Technology 21.97%
2 Industrials 17.6%
3 Healthcare 13.74%
4 Communication Services 10.58%
5 Financials 8.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PAA icon
51
Plains All American Pipeline
PAA
$16.9B
$2.84M 0.22%
103,150
-1,000
-1% -$24.2K
MBLY
52
DELISTED
Mobileye N.V.
MBLY
$2.64M 0.21%
57,190
+920
+2% +$35.2K
IBM icon
53
IBM
IBM
$221B
$2.57M 0.2%
17,682
+523
+3% +$74.9K
MMM icon
54
3M
MMM
$94.2B
$2.3M 0.18%
15,693
WTRG icon
55
Essential Utilities
WTRG
$11.5B
$2.27M 0.18%
63,709
-1,250
-2% -$40.7K
SPY icon
56
State Street SPDR S&P 500 ETF Trust
SPY
$813B
0
ES icon
57
Eversource Energy
ES
$27.2B
$1.92M 0.15%
31,988
-5,545
-15% -$314K
UNP icon
58
Union Pacific
UNP
$174B
$1.57M 0.12%
18,034
-40,027
-69% -$3.38M
JPM icon
59
JPMorgan Chase
JPM
$964B
$1.54M 0.12%
24,724
+1,279
+5% +$79.9K
ESI icon
60
Element Solutions
ESI
$9.46B
$1.33M 0.1%
150,050
-475
-0.3% -$4.42K
SSO icon
61
ProShares Ultra S&P500
SSO
$8.47B
0
CDK
62
DELISTED
CDK Global, Inc.
CDK
$1.31M 0.1%
23,530
BMY icon
63
Bristol-Myers Squibb
BMY
$130B
$1.3M 0.1%
17,722
+227
+1% +$16K
BRK.B icon
64
Berkshire Hathaway Class B
BRK.B
$1.08T
$1.16M 0.09%
7,996
+1,125
+16% +$161K
T icon
65
AT&T
T
$171B
$1.16M 0.09%
35,393
+5,775
+19% +$172K
GLD icon
66
SPDR Gold Trust
GLD
$143B
0
IWV icon
67
iShares Russell 3000 ETF
IWV
$20.5B
0
QQQ icon
68
Invesco QQQ Trust
QQQ
$486B
0
MDY icon
69
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.4B
0
PFE icon
70
Pfizer
PFE
$153B
$759K 0.06%
22,707
+3,076
+16% +$98.2K
INTC icon
71
Intel
INTC
$542B
$714K 0.06%
21,771
-1,290
-6% -$40.4K
MO icon
72
Altria Group
MO
$110B
$543K 0.04%
7,880
-5
-0.1% -$320
LBTYK icon
73
Liberty Global Class C
LBTYK
$3.49B
$488K 0.04%
17,045
-61,132
-78% -$1.93M
VNQ icon
74
Vanguard Real Estate ETF
VNQ
$39.2B
0
NVS icon
75
Novartis
NVS
$287B
$446K 0.03%
6,026

Similar funds

Inverness Counsel's Q2 2016 Portfolio in Review

As of Q2 2016, Inverness Counsel held 102 positions worth $1.29B, down 0.17% from $1.29B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Inverness Counsel's Q2 2016 filing shows 5 new, 23 increased, 41 reduced and 6 closed positions. Its largest new stake was Celgene Corp: 237,842 shares worth $23.5M. The largest sale was Gilead Sciences, an estimated $16M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 25% a quarter earlier, followed by Industrials and Healthcare.

  • Inverness Counsel's largest Q2 2016 buy was Celgene Corp: 237,842 shares worth $23.5M.
  • Inverness Counsel added most to Progressive in Q2 2016, an estimated $19.5M increase.
  • Inverness Counsel's biggest Q2 2016 reduction was Gilead Sciences, cutting an estimated $16M.
  • Inverness Counsel fully exited Moody's in Q2 2016, selling an estimated $13.5M.
  • Inverness Counsel's ten largest holdings make up 43% of its $1.29B portfolio in Q2 2016.
  • Inverness Counsel opened 5 new positions and closed 6 in Q2 2016.
  • Inverness Counsel's portfolio value fell 0.17% quarter-over-quarter to $1.29B.

Based on Inverness Counsel's 13F filing for Q2 2016, filed 4 Aug 2016.